Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study (Q36401915)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study |
scientific article |
Statements
1 reference
Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study (English)
1 reference
Tim D Spector
1 reference
Piotr Krzeski
1 reference
Chris Buckland-Wright
1 reference
Géza Bálint
1 reference
Gary A Cline
1 reference
Karen Stoner
1 reference
Robert Lyon
1 reference
John Beary
1 reference
William S Aronstein
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference